KYNB – kyntra bio, inc. (US:NASDAQ)

News

Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results
Kyntra Bio (KYNB) was upgraded by HC Wainwright to "strong-buy".
Kyntra Bio to Participate in Upcoming Investor Conferences
Kyntra Bio (NASDAQ:KYNB) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com